Pharma Systems Eesti Osaühing
Active Registry code 10329988
OÜ Riidaküla Registered 19 Nov 1997
Pharma Systems Eesti Osaühing is a OÜ based in Riidaküla, registry code 10329988, status: active. Main activity: Manufacture of other medical instruments and supplies. According to EMTA, turnover for Q3 2026 was €195 138 with 23 employees.
Turnover
195 138 €
↓ 19.2% vs Q2 2026
State taxes
59 789 €
↑ 3.8% vs Q2 2026
Labour taxes
63 654 €
↑ 4.2% vs Q2 2026
Employees
23
−1 vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 195 138 €above 83% of companiesindustry median 22 261 € · companies in the industry: 304
- Labour taxes per employee 2 768 €above 73% of companiesindustry median 1 664 € · companies in the industry: 293
- Revenue · 2026 929 441 €above 90% of companiesindustry median 147 444 € · companies in the industry: 12
Taxes and turnover
- Company
- Industry median
Industry: Other manufacturing (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Other manufacturing (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 195 138 | 59 789 | 63 654 | 23 |
| Q2 2026 | 241 429 | 57 599 | 61 066 | 24 |
| Q1 2026 | 240 229 | 58 519 | 62 007 | 24 |
| Q4 2025 | 242 001 | 62 701 | 66 268 | 24 |
| Q3 2025 | 198 832 | 60 918 | 64 449 | 24 |
| Q2 2025 | 231 515 | 57 805 | 61 050 | 24 |
| Q1 2025 | 217 414 | 54 991 | 58 051 | 24 |
| Q4 2024 | 217 664 | 56 884 | 60 364 | 22 |
| Q3 2024 | 192 024 | 63 936 | 67 405 | 23 |
| Q2 2024 | 254 200 | 66 125 | 69 802 | 23 |
| Q1 2024 | 235 694 | 60 664 | 63 939 | 26 |
| Q4 2023 | 237 534 | 62 764 | 66 474 | 26 |
| Q3 2023 | 203 653 | 68 466 | 72 388 | 26 |
| Q2 2023 | 281 714 | 70 167 | 73 860 | 29 |
| Q1 2023 | 276 269 | 66 529 | 70 440 | 32 |
| Q4 2022 | 277 978 | 68 656 | 72 779 | 32 |
| Q3 2022 | 207 985 | 67 827 | 72 121 | 32 |
| Q2 2022 | 262 129 | 62 111 | 66 201 | 32 |
| Q1 2022 | 242 830 | 64 150 | 68 593 | 33 |
Labour taxes per employee per month
923 €
Turnover per employee in the quarter
8 484 €
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Other manufacturing (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Other manufacturing (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Other manufacturing (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Other manufacturing (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2026 | 929 441 | 44 176 | 656 270 | 1 097 550 | 970 041 | 23 |
| 2025 | 857 294 | 40 314 | 614 449 | 1 041 988 | 925 865 | 23 |
| 2024 | 934 702 | 44 274 | 695 291 | 1 002 102 | 885 551 | 25 |
| 2023 | 1 546 095 | 71 975 | 1 129 964 | 973 635 | 841 277 | 32 |
| 2021 | 1 005 182 | 53 190 | 727 879 | 1 019 425 | 609 435 | 34 |
| 2020 | 1 026 880 | 33 770 | 778 579 | 975 741 | 556 245 | 36 |
| 2019 | 905 670 | 36 825 | 680 004 | 919 006 | 522 475 | 30 |
| 2018 | — | — | — | — | — | 41 |
| 2017 | — | — | — | — | — | 42 |
| 2016 | — | — | — | — | — | 46 |
| 2015 | — | — | — | — | — | 48 |
| 2014 | — | — | — | — | — | 47 |
| 2013 | — | — | — | — | — | 44 |
| 2012 | — | — | — | — | — | 48 |
| 2011 | — | — | — | — | — | 54 |
| 2010 | — | — | — | — | — | 54 |
| 2009 | — | — | — | — | — | 52 |
| 2008 | — | — | — | — | — | 62 |
| 2007 | — | — | — | — | — | 60 |
| 2006 | — | — | — | — | — | 44 |
| 2005 | — | — | — | — | — | 43 |
| 2004 | — | — | — | — | — | 30 |
| 2003 | — | — | — | — | — | 25 |
| 2002 | — | — | — | — | — | 23 |
| 2001 | — | — | — | — | — | 21 |
| 2000 | — | — | — | — | — | 17 |
| 1999 | — | — | — | — | — | 12 |
| 1998 | — | — | — | — | — | 12 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2026
Net profit margin
4.8 %
Net profit / revenue
Return on equity (ROE)
4.6 %
Net profit / equity
Return on assets (ROA)
4.0 %
Net profit / assets
Equity ratio
88.4 %
Equity / assets
Debt ratio
11.6 %
Liabilities / assets
Current ratio
4.91
Current assets / current liabilities
Revenue per employee
40 410 €
Revenue / average full-time employees
Labour cost per employee per month
2 378 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jul 2025 – 30 Jun 2026 | 30 Sep 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jul 2024 – 30 Jun 2025 | 17 Sep 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jul 2023 – 30 Jun 2024 | 12 Sep 2024 | Company’s own · audited | e-Äriregister |
| 2022 | 1 Jan 2022 – 30 Jun 2023 | 17 Oct 2023 | Company’s own · audited | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 16 Jun 2022 | Company’s own · audited | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 28 Jun 2021 | Company’s own · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 18 Jun 2020 | Company’s own · audited | e-Äriregister |
Board
- Anja Margareta ThoressonBoard member · since 11 Dec 2023
- Anna Therese GrundénBoard member · since 11 Dec 2023
- Lars Jonas MalmBoard member · since 11 Dec 2023
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Pharma Systems AktiebolagLegal person · 24 925 €
Beneficial owners
- Claes Robert Fleming StjernfeltIndirect ownership · since 21 Dec 2022
Founders and other persons
- Anette Elisabet hedman DanielssonFounder · 20 000 € · 19 Nov 1997
- Aslä Kurt DanielssonFounder · 20 000 € · 19 Nov 1997
- Ivar KiigemägiAudit firm · 17 Jun 2009
- Erki UsinAudit firm · 20 Apr 2010
- Tanel PaideAudit firm · 25 Jun 2014
- Olesia AbramovaAudit firm · 9 Aug 2021
Activities (EMTAK)
- 32509Manufacture of other medical instruments and supplies Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 30029521 / 16 29 Apr 2025 |
Amendment entry | In force 29 Apr 2025 |
||
| Ä 30029521 / 15 28 Apr 2025 |
Entry refused: deficiencies not eliminated | In force 14 May 2025 |
||
| Ä 30029521 / M3 1 Apr 2025 |
Ruling to eliminate deficiencies | 17 Apr 2025 | In force 21 Apr 2025 |
|
| Ä 30029521 / 14 11 Dec 2023 |
Amendment entry | In force 11 Dec 2023 |
||
| Ä 30029521 / 13 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 30029521 / 12 3 May 2023 |
Amendment entry | In force 3 May 2023 |
||
| Ä 30029521 / 11 28 Dec 2022 |
Amendment entry | In force 28 Dec 2022 |
||
| Ä 30029521 / 10 14 Dec 2022 |
Amendment entry | In force 14 Dec 2022 |
||
| Ä 30029521 / M2 27 Jul 2021 |
Procedural ruling | 26 Aug 2021 | Deficiencies eliminated 10 Aug 2021 |
|
| Ä 30029521 / M1 10 Jun 2019 |
Ruling to eliminate deficiencies in the annual report | 10 Jul 2019 | Deficiencies eliminated 17 Jun 2019 |
|
| Ä 30029521 / 9 31 Oct 2018 |
Amendment entry | In force 31 Oct 2018 |
||
| Ä 30029521 / 8 7 Feb 2018 |
Amendment entry | In force 7 Feb 2018 |
||
| Ä 30029521 / 7 18 Jan 2018 |
Amendment entry | In force 18 Jan 2018 |
||
| Ä 30029521 / 6 13 Feb 2017 |
Amendment entry | In force 13 Feb 2017 |
||
| Ä 30029521 / 5 7 Jun 2010 |
Deletion of activities from the registry card | In force 7 Jun 2010 |
||
| Ä 29521 / 2 13 May 2008 |
Amendment entry | In force 13 May 2008 |
||
| Ä 29521 2 Jan 2006 |
Change of registry district | Confirmed 2 Jan 2006 |
||
| Ä 20241 / 4 2 Jan 2006 |
Change of registry district | Confirmed 2 Jan 2006 |
||
| Ä 20241 / 3 7 Feb 2003 |
Published amendment entry | In force | ||
| Ä 20241 / 2 23 Oct 2002 |
Unpublished amendment entry | In force |
Sources: e-Äriregister and EMTA. Data updated 30 Oct 2026. Open at the source ↗ · Report an error in the data